Caligan Partners LP, 10% Owner at STANDARD BIOTOOLS INC. (LAB), bought 25,000 shares at $2.52 ($63K) on 2022-05-10, disclosed to the SEC on 2022-05-10.
Open-market purchase of $63k LAB by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| EXEL | BUY | 2025-11-26 | $2.4M | — | Filing → |
| LQDA | BUY | 2024-09-04 | $1.4M | — | Filing → |
| LQDA | SELL | 2024-09-04 | $1.4M | — | Filing → |